Vivesto
0,229
SEK
-2,35 %
Mindre end 1K følgere
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-2,35%
-1,51%
-0,43%
-21,03%
-14,39%
-23,67%
-78,19%
-96,74%
-98,73%
Vivesto is a pharmaceutical company focused on developing innovative treatments for serious oncology diseases. The company is researching new therapies that can improve patient outcomes and quality of life. The company operates globally with a primary presence in Europe and North America. Vivesto was founded in 1988 and is headquartered in Uppsala, Sweden.
Læs mereMarkedsværdi
123,21 mio. SEK
Aktieomsætning
41,66 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
12.8
2025
Delårsrapport Q2'25
11.11
2025
Delårsrapport Q3'25
12.2
2026
Årsrapport '25
Alle
Selskabspræsentationer
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Report from Annual General Meeting in Vivesto AB
Notice of Annual General Meeting in Vivesto AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools